0.19 USD
↘ 0.02 (10.63%)AT CLOSE (11:59 AM EDT)
Virax Biolabs Group Limited Ordinary Shares
VRAXNASDAQ • USD
0.18
↘ 0.01 (4.81%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
0.18
↘ 0.01 (4.81%)
Market: CLOSED
Open?$0.20
High?$0.20
Low?$0.17
Prev. Close?$0.21
Volume?2.9M
Avg. Volume?N/A
VWAP?$0.19
Bid / Ask
Bid?$0.18 × 100
Ask?$0.18 × 20.0K
Spread?$0.00
Midpoint?$0.18
Valuation & Ratios
Market Cap?1.4M
Shares Out?4.3M
Float?5.5M
Float %?73.5%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
VRAX is currently priced at $0.19. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals. Notable factors include a bearish Death Cross on the long-term moving averages.
Technical & fundamental data as of May 29, 2026.
News
Profile
Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestElevated
Short % of Float?7.17%Elevated
Short Interest?391.3K
Days to Cover?1.0
Free Float5.5M
Avg Daily Volume5.9M
Settlement Date2026-05-15